Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 0.7 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | 0.10 | (4.10) | (3.45)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | n/a | (4.79) | (3.53)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (17.73) | (9.46)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (57.86) | (24.28)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (20.09) | (8.76)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-23 | n/a | (11.00) | (4.63)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | n/a | (7.00) | (2.98)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | n/a | (4.00) | (1.49)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Grant of Options | 15-Nov-2023 | 07:00 | RNS |
Appointment of New Chief Financial Officer | 11-Oct-2023 | 07:00 | RNS |
Interim Results | 21-Sep-2023 | 07:00 | RNS |
Synairgen names Joseph Colliver as CFO | 11-Oct-2023 | ShareCast |
Synairgen posts positive results for phase 2 tri... | 04-Oct-2022 | ShareCast |
Synairgen unveils positive clinical trial data | 07-Sep-2022 | ShareCast |
AstraZeneca buys the rights to an asthma treatme... | 13-Jun-2014 | Daily Mail |
AstraZeneca in new £138million asthma drug deal | 13-Jun-2014 | Express & Star |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 6.63p |
Change Today | -0.50p |
% Change | -7.01 % |
52 Week High | 9.80 |
52 Week Low | 4.88 |
Volume | 635,992 |
Shares Issued | 201.37m |
Market Cap | £13.35m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:20 | 64,608 @ 6.70p |
16:13 | 10,725 @ 6.70p |
15:43 | 39,373 @ 6.70p |
15:27 | 18,608 @ 6.72p |
15:12 | 25,000 @ 6.73p |
You are here: research